UK Biocentre is the not-for-profit provider of bio-sample processing and storage at the National Biosample Centre in Milton Keynes, a 70,000 square foot, purpose-built facility with capacity for 35 million samples.
Established in 2014 with funding from the National Institute for Health Research (NIHR), it was focused on serving the academic sector until, in 2020, it was commissioned by the UK Government to become the first Lighthouse Laboratory to provide rapid COVID-19 PCR testing. During that period, it processed over 100,000 samples a day and more than 31 million in total, at one point providing c. 30% of the UK's coronavirus testing capacity.
UK Biocentre now supports both academic and commercial research, offering end-to-end solutions to the biomedical research community as well as the healthcare, pharmaceutical, and biotech industries. In 2022, it took on the UK’s largest ever health research programme – Our Future Health – which aims to revolutionise the way we fight disease by collecting information from millions of volunteers across the country. Other partners include the NHS and the US biotechnology company GRAIL.
With employee numbers having soared during the pandemic, UK Biocentre now has a team of c.160 and is entering a new phase in its history, as an independent, professional and commercially-focussed organisation. As such, it hopes to forge even more partnerships within the health and life science industries, and remain at the cutting edge of science.